Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Mid-Cap · Marsico

Marsico Midcap Growth Focus Fund Institutional Class (MIDFX)

Ticker MIDFX · Since 2021-12-06 · · Holdings as of Jun 30, 2026

Expense ratio
1.06%$106/yr per $10k
1-yr return
+26.2%as of Dec 2025
Net assets
$939.4Mall share classes
Holdings
43

Bottom line

Is MIDFX a good fund? The bottom line

MIDFX is the Institutional Class share class of Marsico Midcap Growth Focus Fund, a managed mid-cap mutual fund from Marsico.

It charges 1.06% — about $106 a year on every $10,000 invested, more expensive than 66% of mid-cap funds we track.

It returned +26.2% over one year (as of Dec 31, 2025, per its prospectus).

With $939 million in net assets and 43 holdings, its largest position is Revolution Medicines Inc Common Stock (4.4%) and the top 10 make up 36.2% of the portfolio.

What to watch

  • High turnover (106% a year) can mean more taxable distributions

Updated Nov 19, 2026

What MIDFX invests in

The Marsico Midcap Growth Focus Fund's goal is to seek long-term growth of capital.

"The Marsico Midcap Growth Focus Fund is a ""diversified"" mutual fund and invests primarily in common stocks that are selected for their long-term growth potential. The Fund may invest in companies of any size. Under normal circumstances, the Fund will invest at least 80% of the value of its assets in medium-capitalization (or ""mid-cap"") growth companies (""80% Policy""). The Fund will provide shareholders with at least 60 days' prior notice of any future change to the 80% Policy. The Fund defines mid-cap companies to mean companies of sizes similar to those found in the Russell Midcap ? Growth Benchmark Index. The Fund will normally hold a core position of up to 50 common stocks, but the number of securities held by the Fund may occasionally exceed 50 at times such as when the investment adviser to the Fund, Marsico Capital Management, LLC (see ""Management"" below), is…

From the fund's prospectus (filed Jan 27, 2026).

MIDFX performance

Average annual total returns
1 yr5 yr10 yr
MIDFX+26.2%——
Mid-Cap median+7.9%+8.1%+9.9%

Source: Fund prospectus, as of Dec 31, 2025

Full MIDFX performance history →

What MIDFX costs

On a $10,000 investment, MIDFX's 1.06% expense ratio costs about $106 a year. The prospectus estimates $1,294 in total costs over 10 years (assuming 5% annual returns). The median mid-cap fund charges 0.88%.

See the full MIDFX fee table →

MIDFX top 10 holdings

#Holding% of fund
1Revolution Medicines Inc Common Stock RVMD4.38%
2Mks Inc Common Stock MKSI4.17%
3Viking Holdings Ltd Common Stock Usd.01 VIK4.16%
4State Str Instl Invt Tr Treas Mmkt Fd Inst3.62%
5Ge Vernova Inc Common Stock Usd.01 GEV3.52%
6Aar Corp Common Stock Usd1.0 AIR3.38%
7Talen Energy Corp Common Stock Usd.001 TLN3.36%
8Vse Corp Common Stock Usd.05 VSEC3.33%
9Tko Group Holdings Inc Common Stock Usd.00001 TKO3.18%
10Datadog Inc Class A Common Stock Usd.00001 DDOG3.13%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 36.2% of the fund. See all top 25 holdings and asset mix →

Alternatives to MIDFX

More funds like MIDFX →

MIDFX FAQ

What is the expense ratio of MIDFX?
MIDFX's expense ratio is 1.06%, which works out to about $106 a year for every $10,000 invested. The prospectus estimates total costs of $1,294 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is MIDFX a good investment?
It depends on your goals, but the data points to: high turnover (106% a year) can mean more taxable distributions. This is general information, not personalized advice.
What does MIDFX hold?
MIDFX's largest holdings are Revolution Medicines Inc Common Stock (4.4%), Mks Inc Common Stock (4.2%), Viking Holdings Ltd Common Stock Usd.01 (4.2%), State Str Instl Invt Tr Treas Mmkt Fd Inst (3.6%), Ge Vernova Inc Common Stock Usd.01 (3.5%). It holds 43 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
Who manages MIDFX?
MIDFX is offered by Marsico through Marsico Investment Fund.